CL2018001159A1 - Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016) - Google Patents

Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016)

Info

Publication number
CL2018001159A1
CL2018001159A1 CL2018001159A CL2018001159A CL2018001159A1 CL 2018001159 A1 CL2018001159 A1 CL 2018001159A1 CL 2018001159 A CL2018001159 A CL 2018001159A CL 2018001159 A CL2018001159 A CL 2018001159A CL 2018001159 A1 CL2018001159 A1 CL 2018001159A1
Authority
CL
Chile
Prior art keywords
poultry
avian adenovirus
divisional application
vaccine
adenovirus vaccine
Prior art date
Application number
CL2018001159A
Other languages
English (en)
Inventor
Michael Hess
Anna Schachner
Ana Marek
Barbara Jaskulska
Original Assignee
Veterinarmedizinische Univ Wien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48985680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2018001159(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Veterinarmedizinische Univ Wien filed Critical Veterinarmedizinische Univ Wien
Publication of CL2018001159A1 publication Critical patent/CL2018001159A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10211—Aviadenovirus, e.g. fowl adenovirus A
    • C12N2710/10271—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

<p>La presente invención se refiere a una vacuna para usar en la prevención del síndrome de hepatitis/hidropericardio (SHH), hepatitis por cuerpos de inclusión (IBH) o erosión de molleja (GE), preferentemente en aves de corral, especialmente en pollos de engorda, en donde es una vacuna de subunidad que comprende una proteína de fibra de Adenovirus Aviar E (FAdV-E). Adicionalmente se refiere al uso de una vacuna de subunidad que comprende proteína de fibra de FAdV-E, o un fragmento inmunogénico de la misma que sirve para prevenir SHH, IBH o GE en aves, de preferencia en aves de corral, especialmente en pollos de engorda.</p>
CL2018001159A 2013-08-19 2018-04-30 Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016) CL2018001159A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13180860.2A EP2839841A1 (en) 2013-08-19 2013-08-19 Fowl adenovirus vaccine

Publications (1)

Publication Number Publication Date
CL2018001159A1 true CL2018001159A1 (es) 2018-06-22

Family

ID=48985680

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2016000358A CL2016000358A1 (es) 2013-08-19 2016-02-17 Vacuna para adenovirus aviar
CL2018001159A CL2018001159A1 (es) 2013-08-19 2018-04-30 Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2016000358A CL2016000358A1 (es) 2013-08-19 2016-02-17 Vacuna para adenovirus aviar

Country Status (10)

Country Link
US (1) US10220088B2 (es)
EP (2) EP2839841A1 (es)
JP (1) JP6577470B2 (es)
AU (1) AU2014310676B2 (es)
BR (1) BR112016003338B1 (es)
CA (1) CA2921394C (es)
CL (2) CL2016000358A1 (es)
ES (1) ES2896483T3 (es)
MX (1) MX371174B (es)
WO (1) WO2015024929A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2839838A1 (en) 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
EP2839841A1 (en) 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
CN109134646A (zh) * 2017-06-28 2019-01-04 哈药集团生物疫苗有限公司 Ⅰ群血清4型禽腺病毒卵黄抗体的制备方法及其制品
CN110579607A (zh) * 2018-06-08 2019-12-17 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种fadv a病毒间接elisa抗体检测试剂盒及其应用
CN108918869B (zh) * 2018-06-15 2021-12-28 新兴县国研科技有限公司 fiber2蛋白及其重组蛋白在检测血清4型禽腺病毒抗体方面的应用
CN109721642B (zh) * 2018-12-26 2021-08-24 乾元浩生物股份有限公司 一种i群血清4型-血清8型禽腺病毒二价亚单位疫苗及其制备方法
CN110616278B (zh) * 2019-08-09 2022-08-12 山东省农业科学院家禽研究所 检测fav-8和fav-11的特异性引物及试剂盒
CN111269892B (zh) * 2020-03-06 2023-07-11 哈尔滨科欣农业科技有限公司 I群4型禽腺病毒dn株、禽腺病毒灭活疫苗及其制备方法和应用
CN112048570A (zh) * 2020-08-12 2020-12-08 广东省农业科学院动物卫生研究所 一种检测鸭腺病毒4型的pcr引物及其检测方法与应用
CN112626279A (zh) * 2021-01-21 2021-04-09 福建省农业科学院畜牧兽医研究所 检测新发鸭4型腺病毒的实时荧光定量pcr引物及试剂盒
CN112852760A (zh) * 2021-03-04 2021-05-28 温氏食品集团股份有限公司 重组鸭肠炎病毒及其应用
CN113198011B (zh) * 2021-04-28 2023-05-09 重庆永健生物技术有限责任公司 一种鸭腺病毒3型菌株灭活疫苗及其应用
KR102656435B1 (ko) * 2021-12-13 2024-04-11 주식회사 중앙백신연구소 신규한 가금 아데노바이러스 및 이를 유효성분으로 포함하는 가금 아데노바이러스 다가백신
EP4205759A1 (en) 2022-01-04 2023-07-05 Veterinärmedizinische Universität Wien Fowl adenovirus subunit vaccine and production method thereof
CN114703153B (zh) * 2022-06-06 2022-08-02 广东省农业科学院动物卫生研究所 一株血清2型禽腺病毒毒株以及疫苗和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615803A1 (de) 1996-04-20 1997-10-23 Boehringer Ingelheim Int CELO-Virus
WO2003039593A1 (en) 2001-11-08 2003-05-15 Akzo Nobel N.V. Fowl adenovirus vaccine
AU2003209648A1 (en) * 2003-03-04 2004-09-28 Abic Ltd. Subunits of the adenovirus fiber protein and uses thereof as vaccines
US8080642B2 (en) * 2003-05-16 2011-12-20 Vical Incorporated Severe acute respiratory syndrome DNA compositions and methods of use
CA2725435C (en) * 2009-12-15 2023-01-03 University Of Saskatchewan Vaccines for inclusion body hepatitis
EP2839841A1 (en) 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine
EP2839838A1 (en) * 2013-08-19 2015-02-25 Veterinärmedizinische Universität Wien Fowl adenovirus vaccine

Also Published As

Publication number Publication date
CA2921394C (en) 2023-09-05
AU2014310676A2 (en) 2016-05-12
US10220088B2 (en) 2019-03-05
AU2014310676A1 (en) 2016-03-03
BR112016003338B1 (pt) 2023-03-07
US20160199484A1 (en) 2016-07-14
BR112016003338A2 (pt) 2017-11-21
ES2896483T3 (es) 2022-02-24
EP2839841A1 (en) 2015-02-25
CL2016000358A1 (es) 2016-09-09
MX2016002104A (es) 2016-11-11
WO2015024929A2 (en) 2015-02-26
JP6577470B2 (ja) 2019-09-18
AU2014310676B2 (en) 2019-09-12
EP3035963B1 (en) 2021-10-20
JP2016528270A (ja) 2016-09-15
CA2921394A1 (en) 2015-02-26
EP3035963A2 (en) 2016-06-29
WO2015024929A3 (en) 2015-05-07
MX371174B (es) 2020-01-20

Similar Documents

Publication Publication Date Title
CL2018001159A1 (es) Vacuna para adenovirus aviar (divisional de solicitud n° 358-2016)
CL2018000515A1 (es) Virus de la enfermedad de newcastle y usos de los mismos (divisional sol. 2532-2015)
BR112016003317A2 (pt) vacina para adenovírus aviário
BR112018016755A2 (pt) vacina contra o vírus da zica
CL2018002394A1 (es) Subunidades de vacunas de inmersión para peces que comprenden al menos un antígeno aislado de la proteína análoga a histona (hlp) y su uso contra bacterias como flavobacterium. (divisional solicitud 2015000771)
CL2017001961A1 (es) Vacuna bivalente contra el virus de gripe porcina
DOP2015000234A (es) COMPOSICIONES DE ARNi CONTRA EL COMPONENTE C5 DEL COMPLEMENTO Y METODOS PARA SU USO.
CU20200037A7 (es) Derivados de indol-2-carboxamidas sustituidos con amino-tiazol activos contra el virus de la hepatitis b (vhb)
CL2012000620A1 (es) Formulaciones farmaceuticas de un anticuerpo anti cd-20; uso de la formulacion para tratar enfermedad o trastorno que pueda corregirse mediante tratamiento con anticuerpo anti-cd20.
BR112015023507A2 (pt) vacina estável líquida, e, métodos para vacinar um bovino e para produzir uma vacina estável líquida
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
CO6551750A2 (es) Vacuna del virus del dengue inactivado que incluye un adyuvante sin aluminio
CO2017007057A2 (es) Vacuna contra la fiebre aftosa
EA201591579A1 (ru) Способы лечения болезни крона при помощи анти-il-23 антитела
CL2013001877A1 (es) Composicion inmunogenica que comprende un virus de diarrea viral bovina tipo 1b vivo modificado y un portador veterinario aceptable; vacuna que la comprende; y su uso para prevenir, tratar, manejar o aliviar uno o mas sintomas de una enfermedad causada por pestivirus.
BR112017004893A2 (pt) composições e métodos para o tratamento de lesões cutâneas pré-cancerosas
EA201991041A1 (ru) Вакцина против свиного парвовируса и вируса свиного репродуктивного и респираторного синдрома и способы ее получения
BR112017002440A2 (pt) vírus da diarreia epizoótica porcina mutante para utilização em uma vacina
CO2018002207A2 (es) Composiciones contra alergia a los gatos
PE20190121A1 (es) Virus atenuados de bronquitis infecciosa
BR112018077210A8 (pt) Vírus de enterite de pato e usos do mesmo
BR112015031226A2 (pt) Composição de vacina, e, uso da composição de vacina
MX2016002903A (es) Composiciones inmunogenas de la glicoproteina g de los virus hendra y nipah.
UY35418A (es) Vacuna que proporciona protección frente a diferentes Picornavirus humanos.
ECSP12011951A (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria